ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

British Journal of Dermatology

British Journal of Dermatology

Volume 109 Issue 3, Pages 321 - 326

Published Online: 29 Jul 2006

Journal compilation © 2010 British Association of Dermatologists



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 265K)  | Related Articles | Citation Tracking

Topical acyclovir in the management of recurrent herpes labialis
A.P. FIDDIAN 1 LUDMILA IVANYI*
  1 Department of Clinical Immunology and Chemotherapy, The Wellcome Research Laboratories, Beckenham, Kent   *Department of Clinical Pathology and Immunology, Institute of Dental Surgery, Eastman Dental Hospital, London
 Correspondence: Dr A.P. Fiddian, Wellcome Research Laboratories, Langley Court, Beckenham, Kent, BR3 3BS.
Copyright 1983 British Association of Dermatologists

ABSTRACT

AbstractReferences

A double-blind, randomized, placebo-controlled trial of 5% acyclovir ointment was carried out for thirty-one episodes of herpes labialis in thirteen patients experiencing severe, frequent recurrences. In addition, these patients continued to use acyclovir ointment or placebo for the treatment of twenty-two further episodes. Treatment was initiated by the patients as soon as possible after onset of prodromal symptoms, and continued five times a day for 5 days. It was found that acyclovir ointment shortened the duration of lesions only by about one day, but it greatly increased the number of abortive lesions resulting from early application. Acyclovir ointment is well tolerated and appears to modify the course of severe recurrent herpes labialis when therapy is initiated by the patient during the prodrome.


Accepted for publication 7 February 1983

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1365-2133.1983.tb03548.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Sign Up Now
Wiley Medical Twitter